Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Taiwan Semiconductor Mfg. Co. Ltd. (TSM) vs GeneDx Holdings Corp (WGS) Price & Performance

Taiwan Semiconductor Mfg. Co. Ltd.Trade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Taiwan Semiconductor Mfg. Co. Ltd. vs GeneDx Holdings Corp — how do they compare? Taiwan Semiconductor Mfg. Co. Ltd. trades at $430.65 (market cap $1.93T), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: Taiwan Semiconductor Mfg. Co. Ltd. is far larger — about 791× GeneDx Holdings Corp's market cap, and Taiwan Semiconductor Mfg. Co. Ltd. pays a 0.9% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

TSMWGS
Market Cap
$1.93T$2.44B
Sector
TechnologyTechnology
52-Week High
$477.57$167.51
52-Week Low
$227.33$34.51
Enterprise Value
$1.85T$2.48B
Dividend Yield
0.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Taiwan Semiconductor Mfg. Co. Ltd.

Taiwan Semiconductor Manufacturing (TSM) trades at $432.11, up 3.26% today, with a bullish technical signal and strong earnings momentum after beating estimates for three consecutive quarters. Revenue growth is robust, with July 2026 sales up 44.7% year-over-year (Bloomberg, 2026-08-10), driven by AI demand. The stock is supported by high profitability margins and a consensus analyst price target of $545.67, indicating significant upside potential.

The outlook remains positive given accelerating AI-driven revenue and expansion investments, but risks include geopolitical tensions in Taiwan and competitive pressures. Valuation multiples are elevated, with a P/E of 31.86, requiring sustained growth to justify current levels. Institutional sentiment is strongly bullish, with 72% of analysts rating the stock a buy.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.

Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Taiwan Semiconductor Mfg. Co. Ltd.

Taiwan Semiconductor Manufacturing Company, or TSMC, is the world's largest dedicated chip foundry, with over 57% market share in 2021 per Gartner. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public as an ADR in the U.S. in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious customer base, including Apple, AMD and Nvidia, that looks to apply cutting-edge process technologies to its semiconductor designs.

Read more on TSM

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS